At 3.5 years, apixaban beats aspirin for cost-effectiveness | Medical Informer

Home

Home » Medicine & Supplements » Aspirin » At 3.5 years, apixaban beats aspirin for cost-effectiveness

At 3.5 years, apixaban beats aspirin for cost-effectiveness

Posted on 09 August 2012. Tags: apixaban, Aspirin, beats, costeffectiveness, Years

At 3.5 years, apixaban beats aspirin for cost-effectiveness
Apixaban falls short of aspirin as a cost-effective stroke preventive strategy for atrial fibrillation (AF) patients who are unsuitable for warfarin, but only in the short term, according to an analysis in the July issue of Circulation: Cardiovascular …

Full News here – Read more on Cardiovascular Business

Leave a Reply Cancel reply

Latest
Popular
Comments
Tags
Subscribe

Comedian Tom Stade on close to the bone jokes and Frankie Boyle May 25, 2013
One in five of people with asthma are sensitive to aspirin May 25, 2013
Barnstable District Court May 25, 2013
Moms Receive Life-Changing Gift of Sight May 25, 2013
New device claims to give asthma sufferers relief May 25, 2013

lasik November 2, 2011
CT scan (3/13) – Medical Informer Video November 12, 2011
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video November 23, 2011
Aspirin Toner – Medical Informer Video November 29, 2011
Animation about diabetes and the body. – Medical Informer Video December 5, 2011